Showing results (111-120 of 281) with videos related to
Sort By:
Pageof 29
Cold Spring Harbor Molecular Case Studies|February 17, 2018
Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosityLorena P Suarez-Kelly, Keiko Akagi, Julie W Reeser, et al.Blood|January 5, 2008
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gammaSri Vidya Kondadasula, Julie M Roda, Robin Parihar, et al.Urologic Oncology|January 13, 2021
Neoadjuvant chemotherapy in bladder cancer: Clinical benefit observed in prospective trials computed with restricted mean survival timesZachary R McCaw, Anobel Y Odisho, Hemant Chaparala, et al.Journal of Visualized Experiments : Jove|July 10, 2018
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 RibonucleoproteinsMeisam Naeimi Kararoudi, Hamid Dolatshad, Prashant Trikha, et al.Breast Cancer Research and Treatment|December 4, 2008
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumabAruna Mani, Julie Roda, Donn Young, et al.American Journal of Clinical Oncology|May 12, 2010
A pilot study of bevacizumab and interferon-α2b in ocular melanomaKristan D Guenterberg, Valerie P Grignol, Kiran V Relekar, et al.Cancer Immunology, Immunotherapy : CII|July 25, 2019
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neckAshley Pinette, Elizabeth McMichael, Nicholas B Courtney, et al.Cancer Immunology, Immunotherapy : CII|January 15, 2008
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assaySri Vidya Kondadasula, Kimberly A Varker, Gregory B Lesinski, et al.Blood|December 18, 2004
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulationRossana Trotta, Robin Parihar, Jianhua Yu, et al.NPJ Systems Biology and Applications|March 2, 2019
Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypesKelly E Regan-Fendt, Jielin Xu, Mallory DiVincenzo, et al.Pageof 29